Logo image of ALNXT.PA

NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

Europe - EPA:ALNXT - FR0004171346 - Common Stock

0.473 EUR
+0.01 (+1.28%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, ALNXT scores 5 out of 10 in our fundamental rating. ALNXT was compared to 69 industry peers in the IT Services industry. While ALNXT seems to be doing ok healthwise, there are quite some concerns on its profitability. An interesting combination arises when we look at growth and value: ALNXT is growing strongly while it also seems undervalued.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALNXT had positive earnings in the past year.
ALNXT had a positive operating cash flow in the past year.
Each year in the past 5 years ALNXT has been profitable.
ALNXT had a positive operating cash flow in 4 of the past 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

The Return On Assets of ALNXT (2.48%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 4.95%, ALNXT is in line with its industry, outperforming 42.03% of the companies in the same industry.
ALNXT has a worse Return On Invested Capital (6.08%) than 60.87% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALNXT is significantly below the industry average of 11.46%.
Industry RankSector Rank
ROA 2.48%
ROE 4.95%
ROIC 6.08%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

Looking at the Profit Margin, with a value of 2.35%, ALNXT is in line with its industry, outperforming 43.48% of the companies in the same industry.
In the last couple of years the Profit Margin of ALNXT has declined.
The Operating Margin of ALNXT (4.77%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALNXT has declined.
ALNXT's Gross Margin of 55.35% is in line compared to the rest of the industry. ALNXT outperforms 44.93% of its industry peers.
In the last couple of years the Gross Margin of ALNXT has declined.
Industry RankSector Rank
OM 4.77%
PM (TTM) 2.35%
GM 55.35%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALNXT is destroying value.
ALNXT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALNXT has been increased compared to 5 years ago.
The debt/assets ratio for ALNXT has been reduced compared to a year ago.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 1.92 indicates that ALNXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALNXT has a Altman-Z score of 1.92. This is in the lower half of the industry: ALNXT underperforms 63.77% of its industry peers.
ALNXT has a debt to FCF ratio of 2.63. This is a good value and a sign of high solvency as ALNXT would need 2.63 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.63, ALNXT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that ALNXT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.15, ALNXT is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.63
Altman-Z 1.92
ROIC/WACC0.53
WACC11.54%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.18 indicates that ALNXT should not have too much problems paying its short term obligations.
With a Current ratio value of 1.18, ALNXT perfoms like the industry average, outperforming 49.28% of the companies in the same industry.
A Quick Ratio of 1.18 indicates that ALNXT should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.18, ALNXT perfoms like the industry average, outperforming 57.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

7

3. Growth

3.1 Past

ALNXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 216.26%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.66% on average over the past years.
Looking at the last year, ALNXT shows a small growth in Revenue. The Revenue has grown by 6.76% in the last year.
The Revenue has been growing by 21.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)216.26%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%90.52%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%3.58%

3.2 Future

ALNXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.47% yearly.
The Revenue is expected to grow by 8.18% on average over the next years. This is quite good.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.82 indicates a reasonable valuation of ALNXT.
85.51% of the companies in the same industry are more expensive than ALNXT, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.41. ALNXT is valued rather cheaply when compared to this.
ALNXT is valuated cheaply with a Price/Forward Earnings ratio of 5.07.
ALNXT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALNXT is cheaper than 94.20% of the companies in the same industry.
ALNXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.83
Fwd PE 5.07
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

79.71% of the companies in the same industry are more expensive than ALNXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.28
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

ALNXT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.57
PEG (5Y)3.23
EPS Next 2Y9.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALNXT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXTEDIA

EPA:ALNXT (9/18/2025, 7:00:00 PM)

0.473

+0.01 (+1.28%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap18.45M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.83
Fwd PE 5.07
P/S 0.29
P/FCF 7.28
P/OCF 7.09
P/B 0.6
P/tB 42.71
EV/EBITDA N/A
EPS(TTM)0.04
EY8.46%
EPS(NY)0.09
Fwd EY19.73%
FCF(TTM)0.06
FCFY13.73%
OCF(TTM)0.07
OCFY14.11%
SpS1.66
BVpS0.79
TBVpS0.01
PEG (NY)0.57
PEG (5Y)3.23
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 4.95%
ROCE 8.55%
ROIC 6.08%
ROICexc 8.32%
ROICexgc N/A
OM 4.77%
PM (TTM) 2.35%
GM 55.35%
FCFM 3.92%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.63
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.11%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 166.85%
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z 1.92
F-Score7
WACC11.54%
ROIC/WACC0.53
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)216.26%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%90.52%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.76%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%3.58%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.78%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.05%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y79.43%
OCF growth 3Y-10.82%
OCF growth 5YN/A